Literature DB >> 24317128

Minor RBC Ab and allo-SCT.

G S Booth1, E A Gehrie2, B N Savani3.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24317128     DOI： 10.1038/bmt.2013.196

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  24 in total

1.  Detection of anti-D in D- recipients transfused with D+ red blood cells.

Authors:  Mark H Yazer; Darrell J Triulzi
Journal:  Transfusion       Date:  2007-08-21       Impact factor: 3.157

2.  Low risk of alloimmunization to the D antigen in D- orthotopic liver transplant recipients receiving D+ RBCs perioperatively.

Authors:  Shan Yuan; Rebecca Davis; Qun Lu; Dennis Goldfinger; Alyssa F Ziman
Journal:  Transfusion       Date:  2008-12       Impact factor: 3.157

3.  Long-term follow-up testing of red cell alloantibodies.

Authors:  G Ramsey; S J Smietana
Journal:  Transfusion       Date:  1994-02       Impact factor: 3.157

4.  Rh-incompatible platelet transfusions--risks and consequences of sensitizing immunosuppressed patients.

Authors:  D Goldfinger; M H McGinniss
Journal:  N Engl J Med       Date:  1971-04-29       Impact factor: 91.245

5.  Primary immunization of Rh-negative volunteers.

Authors:  H H Gunson; F Stratton; D G Cooper; V I Rawlinson
Journal:  Br Med J       Date:  1970-03-07

6.  Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation.

Authors:  P P Young; L T Goodnough; P Westervelt; J F Diersio
Journal:  Bone Marrow Transplant       Date:  2001-06       Impact factor: 5.483

7.  Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.

Authors:  Barbara Zupańska; J Maciej Zaucha; Bogumila Michalewska; Aniela Malinowska; Ewa Brojer; Andrzej Hellmann
Journal:  Transfusion       Date:  2005-01       Impact factor: 3.157

Review 8.  Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.

Authors:  S D Rowley; M L Donato; P Bhattacharyya
Journal:  Bone Marrow Transplant       Date:  2011-09       Impact factor: 5.483

9.  Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients.

Authors:  M L Baldwin; P M Ness; D Scott; H Braine; T S Kickler
Journal:  Transfusion       Date:  1988 Jul-Aug       Impact factor: 3.157

10.  Probability of anti-D development in D- patients receiving D+ RBCs.

Authors:  Christoph Frohn; Lutz Dümbgen; Jörg-Matthias Brand; Siegfried Görg; Jürgen Luhm; Holger Kirchner
Journal:  Transfusion       Date:  2003-07       Impact factor: 3.157
View more
  3 in total

1.  An unusual case of red blood cell immunisation following liver transplantation.

Authors:  Cecilia Pardi; Mihai Oltean
Journal:  Blood Transfus       Date:  2015-05-20       Impact factor: 3.443

2.  Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT.

Authors:  C K Brierley; T J Littlewood; A J Peniket; R Gregg; J Ward; A Clark; A Parker; R Malladi; P Medd
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

Review 3.  The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders.

Authors:  Eric A Gehrie; Christopher A Tormey
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.